Refine
Year of publication
- 2021 (2633)
- 2020 (2208)
- 2022 (2064)
- 2019 (1861)
- 2018 (1799)
- 2017 (1706)
- 2016 (1482)
- 2023 (1444)
- 2015 (1278)
- 2012 (1235)
- 2014 (1234)
- 2013 (1151)
- 2011 (963)
- 2009 (881)
- 2010 (876)
- 2024 (816)
- 2008 (801)
- 2007 (645)
- 2006 (627)
- 2005 (604)
- 2004 (509)
- 2003 (497)
- 2001 (400)
- 2002 (385)
- 2000 (315)
- 1999 (259)
- 1998 (203)
- 1997 (143)
- 1996 (133)
- 1995 (126)
- 1993 (108)
- 1994 (99)
- 1992 (89)
- 1990 (76)
- 1991 (60)
- 1989 (57)
- 1986 (48)
- 1988 (44)
- 1985 (43)
- 1981 (38)
- 1983 (36)
- 1982 (32)
- 1984 (32)
- 1976 (30)
- 1987 (29)
- 1980 (28)
- 1977 (22)
- 1971 (21)
- 1974 (21)
- 1975 (21)
- 1978 (18)
- 1979 (18)
- 1972 (17)
- 1969 (16)
- 1966 (14)
- 1973 (12)
- 1964 (11)
- 1967 (11)
- 1970 (11)
- 1908 (10)
- 1915 (10)
- 1923 (10)
- 1926 (10)
- 1937 (10)
- 1938 (10)
- 1893 (9)
- 1909 (9)
- 1965 (9)
- 1913 (8)
- 1936 (8)
- 1897 (7)
- 1898 (7)
- 1920 (7)
- 1935 (7)
- 1940 (7)
- 1961 (7)
- 1894 (6)
- 1896 (6)
- 1901 (6)
- 1903 (6)
- 1904 (6)
- 1910 (6)
- 1911 (6)
- 1912 (6)
- 1918 (6)
- 1922 (6)
- 1924 (6)
- 1927 (6)
- 1930 (6)
- 1933 (6)
- 1958 (6)
- 1881 (5)
- 1887 (5)
- 1900 (5)
- 1917 (5)
- 1919 (5)
- 1931 (5)
- 1957 (5)
- 1968 (5)
- 1842 (4)
- 1859 (4)
- 1862 (4)
- 1868 (4)
- 1890 (4)
- 1891 (4)
- 1899 (4)
- 1906 (4)
- 1914 (4)
- 1916 (4)
- 1928 (4)
- 1929 (4)
- 1942 (4)
- 1959 (4)
- 1962 (4)
- 1843 (3)
- 1846 (3)
- 1854 (3)
- 1857 (3)
- 1860 (3)
- 1870 (3)
- 1871 (3)
- 1875 (3)
- 1876 (3)
- 1880 (3)
- 1882 (3)
- 1885 (3)
- 1888 (3)
- 1892 (3)
- 1905 (3)
- 1921 (3)
- 1925 (3)
- 1934 (3)
- 1939 (3)
- 1943 (3)
- 1946 (3)
- 1947 (3)
- 1948 (3)
- 1952 (3)
- 1953 (3)
- 1960 (3)
- 1963 (3)
- 1743 (2)
- 1825 (2)
- 1835 (2)
- 1836 (2)
- 1838 (2)
- 1855 (2)
- 1856 (2)
- 1858 (2)
- 1869 (2)
- 1874 (2)
- 1879 (2)
- 1883 (2)
- 1884 (2)
- 1886 (2)
- 1902 (2)
- 1907 (2)
- 1932 (2)
- 1597 (1)
- 1757 (1)
- 1762 (1)
- 1770 (1)
- 1798 (1)
- 1800 (1)
- 1812 (1)
- 1816 (1)
- 1818 (1)
- 1820 (1)
- 1822 (1)
- 1830 (1)
- 1837 (1)
- 1840 (1)
- 1844 (1)
- 1845 (1)
- 1848 (1)
- 1850 (1)
- 1853 (1)
- 1861 (1)
- 1863 (1)
- 1865 (1)
- 1866 (1)
- 1872 (1)
- 1873 (1)
- 1878 (1)
- 1895 (1)
- 1941 (1)
- 1944 (1)
- 1945 (1)
- 1949 (1)
- 1950 (1)
- 1951 (1)
- 1954 (1)
- 1956 (1)
Document Type
- Article (16364)
- Part of Periodical (2825)
- Working Paper (2365)
- Preprint (2322)
- Doctoral Thesis (2082)
- Book (1738)
- Conference Proceeding (1235)
- Part of a Book (1071)
- Report (471)
- Review (166)
Language
- English (30837) (remove)
Keywords
- taxonomy (752)
- new species (451)
- morphology (180)
- Deutschland (142)
- Syntax (126)
- Englisch (120)
- distribution (118)
- biodiversity (104)
- inflammation (101)
- Deutsch (98)
Institute
- Medizin (5467)
- Physik (4302)
- Wirtschaftswissenschaften (1941)
- Frankfurt Institute for Advanced Studies (FIAS) (1886)
- Biowissenschaften (1575)
- Informatik (1525)
- Center for Financial Studies (CFS) (1506)
- Biochemie und Chemie (1097)
- Sustainable Architecture for Finance in Europe (SAFE) (1085)
- House of Finance (HoF) (718)
Tens of thousands of man-made chemicals are in regular use and discharged into the environment. Many of them are known to interfere with the hormonal systems in humans and wildlife. Given the complexity of endocrine systems, there are many ways in which endocrine-disrupting chemicals (EDCs) can affect the body’s signaling system, and this makes unraveling the mechanisms of action of these chemicals difficult. A major concern is that some of these EDCs appear to be biologically active at extremely low concentrations. There is growing evidence to indicate that the guiding principle of traditional toxicology that “the dose makes the poison” may not always be the case because some EDCs do not induce the classical dose–response relationships. The European Union project COMPRENDO (Comparative Research on Endocrine Disrupters—Phylogenetic Approach and Common Principles focussing on Androgenic/Antiandrogenic Compounds) therefore aims to develop an understanding of potential health problems posed by androgenic and antiandrogenic compounds (AACs) to wildlife and humans by focusing on the commonalities and differences in responses to AACs across the animal kingdom (from invertebrates to vertebrates).
Polyploidy is common in higher eukaryotes, especially in plants, but it is generally assumed that most prokaryotes contain a single copy of a circular chromosome and are therefore monoploid. We have used two independent methods to determine the genome copy number in halophilic archaea, 1) cell lysis in agarose blocks and Southern blot analysis, and 2) Real-Time quantitative PCR. Fast growing H. salinarum cells contain on average about 25 copies of the chromosome in exponential phase, and their ploidy is downregulated to 15 copies in early stationary phase. The chromosome copy number is identical in cultures with a twofold lower growth rate, in contrast to the results reported for several other prokaryotic species. Of three additional replicons of H. salinarum, two have a low copy number that is not growth-phase regulated, while one replicon even shows a higher degree of growth phase-dependent regulation than the main replicon. The genome copy number of H. volcanii is similarly high during exponential phase (on average 18 copies/cell), and it is also downregulated (to 10 copies) as the cells enter stationary phase. The variation of genome copy numbers in the population was addressed by fluorescence microscopy and by FACS analysis. These methods allowed us to verify the growth phase-dependent regulation of ploidy in H. salinarum, and they revealed that there is a wide variation in genome copy numbers in individual cells that is much larger in exponential than in stationary phase. Our results indicate that polyploidy might be more widespread in archaea (or even prokaryotes in general) than previously assumed. Moreover, the presence of so many genome copies in a prokaryote raises questions about the evolutionary significance of this strategy.
Why is it hard to divide attention between dissimilar activities, such as reading and listening to a conversation? We used functional magnetic resonance imaging (fMRI) to study interference between simple auditory and visual decisions, independently of motor competition. Overlapping activity for auditory and visual tasks performed in isolation was found in lateral prefrontal regions, middle temporal cortex and parietal cortex. When the visual stimulus occurred during the processing of the tone, its activation in prefrontal and middle temporal cortex was suppressed. Additionally, reduced activity was seen in modality-specific visual cortex. These results paralleled impaired awareness of the visual event. Even without competing motor responses, a simple auditory decision interferes with visual processing on different neural levels, including prefrontal cortex, middle temporal cortex and visual regions.
Background and Aim: In Germany, the discharge medication is usually reported to the general practitioner (GP) by an inital short report (SR) /notification (handed over to the patient) and later by a more detailed discharge letter (DL) of the hospital.
Material and Method: We asked N=536 GPs (from Frankfurt/Main and Luebeck) after the typical report format of their patients discharge medication by the local hospitals. The questionnaire asked for 26 items covering (1) the designation of the medication (brand name, generic name) in SR and DL, (2) further specifications e.g. possibilities of generic substitution or supervision of sensible medications, (3) reasons why GPs do not follow the hospitals recommendations and (4) possibilities for an improvement in the medication-related communication between GP and hospitals.
Results: 39% GPs responded sufficiently to the questionnaire. The majority of the GPs (82%) quoted that in the SR only brand names are given (often or ever) and neither the generic name or any further information on generic substitution is available (seldom or never). 65% of the responders quoted that even in the DL only brand names are given. Only 41% of the responders quoted that further treatment relevant specifications are given (often or ever). 95% responded that new medications or change of custom medication is seldom or never explained in the DL and GP were not explicitly informed about relevant medication changes. 58% of the responders quoted economic reasons for re-adjustment of the discharge medication e.g. by generic substitution. The majority of responders (83%) are favouring (useful or very useful) a pre-discharge information (e.g. via fax) about the medication and 54% a hot-line to some relevant person in the hospital when treatment problems emerge. 67% of the responders quoted in favour of regular meetings between GPs and hospital doctors regarding actual pharmacotherapy.
Conclusion: In conclusion, our survey pointed to marked deficiencies in reporting the discharge medication to GPs.
Conflict of interest: None
Background The detection of the new Coranavirus (CoV) causing agent of the severe acute respiratory syndrome (SARS) for diagnostic purposes is still a critical step in prevention of secondary hospital infections. In this respect the PCR for SARS diagnostic is the fastest and most sensitive method and was published very early after the description of the new pathogen by different groups. To evaluate the quality and sensitivity of the SARS PCR performed in diagnostic laboratories all over the world an external quality assurance (EQA) for SARS PCR was initiated by the WHO, the European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) and the Robert Koch-Institut. Methods Therefore 10 samples of inactivated SARS CoV strains isolated in Frankfurt and Hong Kong in different dilutions and negative controls were prepared. The freeze dried samples were send by mail to 62 different laboratories, in 37 countries in Europe and Israel (35), Asia (11), The Americas (11), Australia and New Zealand (4) and Africa (1). The results were returned by email or fax 1 week (13), 2 weeks (14), 3 weeks (6) and later (29) after receiving the material which does not mimic at all the possible speed of this fast method. But this was not considered in the evaluation of these first SARS EQA. Results 44 laboratories showed good or excellent results (26 = 100%, 18 = 90%) and even the 14 laboratories which archived only 80% (10) or 70% (4) correct results are mostly lacking sensitivity. The results of the other 4 laboratories show basic problems in regard to sensitivity, specificity and consistency of results and must be overcome as soon as possible. 4 laboratories seem to have problems with the specificity finding a positive signal in negative samples. The different methods used for preparation of the SARS CoV genome and diagnostic PCR test procedure used by the participating laboratories will be discussed in more detail in the presentation. Conclusion However, in contrast to previous EQAs for Ebola, Lassa and Orthopoxviruses the quality of PCR results was rather good which might be caused by the early publication and distribution of well developed PCR methods. An EQA for evaluation of SARS specific serology is still ongoing, first results will be available beginning of April 2004.
Objective: Establishment of an immunocompetent mouse model representing the typical progressive stages observed in malignant human gliomas for the in vivo evaluation of novel target-specific regimens.
Methods: Isolated clones from tumours that arose spontaneously in GFAP-v-src transgenic mice were used to develop a transplantable brain tumour model in syngeneic B6C3F1 mice. STAT3 protein was knocked down by infection of tumour cells with replication-defective lentivirus encoding STAT3-siRNA. Apoptosis is designed to be induced by soluble recombinant TRAIL + chemical Bcl-2/Bcl-xL inhibitors.
Results: Striatal implantation of 105 mouse tumour cells resulted in the robust development of microscopically (2 – 3 mm) infiltrating malignant gliomas. Immunohistochemically, the gliomas displayed the astroglial marker GFAP and the oncogenic form of STAT3 (Tyr-705-phosphorylated) which is found in many malignancies including gliomas. Phosphorylated STAT3 was particularly prominent in the nucleus but was also found at the plasma membrane of peripherally infiltrating glioma cells. To evaluate the role of STAT3 in tumour progression, we stably expressed siRNA against STAT3 in several murine glioma cell lines. The effect of STAT3 depletion on proliferation, invasion and survival will be first assessed in vitro and subsequently after transplantation in vivo. Upstream and downstream components of the STAT3 signalling pathway as well as possible non-specific side effects of STAT3-siRNA expression after lentiviral infection will be examined, too.
Conclusions: Its high rate of engraftment, its similarity to the malignant glioma of origin, and its rapid locally invasive growth should make this murine model useful in testing novel therapies for malignant gliomas.
Spatial interpolation of precipitation data is uncertain. How important is this uncertainty and how can it be considered in evaluation of high-resolution probabilistic precipitation forecasts? These questions are discussed by experimental evaluation of the COSMO consortium's limited-area ensemble prediction system COSMO-LEPS. The applied performance measure is the often used Brier skill score (BSS). The observational references in the evaluation are (a) analyzed rain gauge data by ordinary Kriging and (b) ensembles of interpolated rain gauge data by stochastic simulation. This permits the consideration of either a deterministic reference (the event is observed or not with 100% certainty) or a probabilistic reference that makes allowance for uncertainties in spatial averaging. The evaluation experiments show that the evaluation uncertainties are substantial even for the large area (41 300 km2) of Switzerland with a mean rain gauge distance as good as 7 km: the one- to three-day precipitation forecasts have skill decreasing with forecast lead time but the one- and two-day forecast performances differ not significantly.
This paper documents the experiences of assurance evaluation during the early stage of a large software development project. This project researches, contracts and integrates privacy-respecting software to business environments. While assurance evaluation with ISO 15408 Common Criteria (CC) within the certification schemes is done after a system has been completed, our approach executes evaluation during the early phases of the software life cycle. The promise is to increase quality and to reduce testing and fault removal costs for later phases of the development process. First results from the still-ongoing project suggests that the Common Criteria can define a framework for assurance evaluation in ongoing development projects.